ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for smarter Trade smarter, not harder: Unleash your inner pro with our toolkit and live discussions.

ALLO Allogene Therapeutics Inc

2.76
-0.25 (-8.31%)
May 17 2024 - Closed
Delayed by 15 minutes

Income Statement

Balance Sheet

Cash Flow

Quarter End Mar 2022Jun 2022Sep 2022Dec 2022Mar 2023Jun 2023Sep 2023Dec 2023
USD (US$)USD (US$)USD (US$)USD (US$)USD (US$)USD (US$)USD (US$)
Total Revenue 61k86k49k47k52k44k43k-44k
Operating Income -79.99M-76.59M-82.49M-96.37M-99.07M-80.52M-62.98M-71.93M
Pre Tax Income -79.85M-74.79M-83.15M-94.85M-98.7M-77.99M-61.32M-89.26M
Net Income -79.85M-74.79M-83.15M-94.85M-98.7M-77.99M-61.32M-89.26M
Preferred Dividends 00000000
Basic Earnings Per Share (EPS) 00000000
EBIT -80.34M-75.45M-83.01M-97.6M-100.76M-81.77M-64.52M-78.28M
EBITDA -76.3M-72.92M-78.63M-93.3M-95.56M-76.88M-59.4M-68.45M
Year End December 30 2023 2017201820192020202120222023
USD (US$)USD (US$)USD (US$)USD (US$)USD (US$)USD (US$)USD (US$)
Total Revenue 000038.49M243k95k
Operating Income -2k-192.84M-202.01M-258.24M-255.79M-335.45M-314.49M
Pre Tax Income -2k-211.62M-184.93M-250.22M-257.01M-332.63M-327.27M
Net Income -2k-211.51M-184.59M-250.22M-257.01M-332.63M-327.27M
Preferred Dividends 0000000
Basic Earnings Per Share (EPS) 0-1.741-1.485-1.781-1.802-2.303-1.945
EBIT -2k-214.05M-202.28M-259.39M-258.72M-337.2M-325.33M
EBITDA -2k-191.34M-196.81M-250.66M-245.34M-321.15M-300.29M